Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Excitatory Amino Acid Receptors”

4 trials

Showing 4 of 4 results

Post-approval studies (Phase 4)Study completedNCT05615948
What this trial is testing

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive DisorderAnalgesia+10 more
Maimonides Medical Center 15
Early research (Phase 1)Study completedNCT00538798
What this trial is testing

PET Imaging of Brain mGluR5 Receptors Using [18F]SP203

Who this might be right for
HealthyGlutamate ReceptormGlur5 Protein+3 more
National Institute of Mental Health (NIMH) 50
Large-scale testing (Phase 3)Study completedNCT02967640
What this trial is testing

Does Subacromial Injection With Glutamate Receptor Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?

Who this might be right for
Rotator Cuff TendinitisChronic Pain
Helse Møre og Romsdal HF 14
Testing effectiveness (Phase 2)Study completedNCT03051256
What this trial is testing

Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD

Who this might be right for
Depressive Disorder, MajorDepressive Disorder, Treatment-Resistant
Relmada Therapeutics, Inc. 62

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation